Luxturna gene therapy
Credit: OHSU News
Caspian Soto, 4, is among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, is wheeled into the operating room September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)